BB Biotech’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $627M | Sell |
7,725,000
-1,016,334
| -12% | -$82.5M | 15.76% | 1 |
|
2018
Q4 | $473M | Buy |
8,741,334
+75,000
| +0.9% | +$4.05M | 15.14% | 1 |
|
2018
Q3 | $447M | Hold |
8,666,334
| – | – | 11.83% | 1 |
|
2018
Q2 | $361M | Buy |
8,666,334
+150,000
| +2% | +$6.25M | 10.43% | 1 |
|
2018
Q1 | $375M | Buy |
8,516,334
+380,000
| +5% | +$16.8M | 10.37% | 1 |
|
2017
Q4 | $409M | Buy |
8,136,334
+274,400
| +3% | +$13.8M | 11.52% | 1 |
|
2017
Q3 | $399M | Buy |
7,861,934
+507,839
| +7% | +$25.7M | 11.03% | 3 |
|
2017
Q2 | $374M | Sell |
7,354,095
-107,200
| -1% | -$5.45M | 11.43% | 3 |
|
2017
Q1 | $300M | Buy |
7,461,295
+548,123
| +8% | +$22M | 9.81% | 3 |
|
2016
Q4 | $331M | Sell |
6,913,172
-250,000
| -3% | -$12M | 12.25% | 3 |
|
2016
Q3 | $262M | Buy |
7,163,172
+58,334
| +0.8% | +$2.14M | 9.23% | 3 |
|
2016
Q2 | $165M | Buy |
7,104,838
+325,000
| +5% | +$7.57M | 6.53% | 4 |
|
2016
Q1 | $275M | Buy |
6,779,838
+250,000
| +4% | +$10.1M | 10.91% | 3 |
|
2015
Q4 | $404M | Sell |
6,529,838
-105,000
| -2% | -$6.5M | 11.39% | 3 |
|
2015
Q3 | $268M | Buy |
6,634,838
+705,412
| +12% | +$28.5M | 8.5% | 5 |
|
2015
Q2 | $341M | Buy |
5,929,426
+200,000
| +3% | +$11.5M | 9.25% | 3 |
|
2015
Q1 | $365M | Sell |
5,729,426
-247,100
| -4% | -$15.7M | 10.87% | 2 |
|
2014
Q4 | $369M | Sell |
5,976,526
-660,000
| -10% | -$40.7M | 11.95% | 2 |
|
2014
Q3 | $258M | Sell |
6,636,526
-70,000
| -1% | -$2.72M | 10.48% | 3 |
|
2014
Q2 | $231M | Buy |
6,706,526
+405,000
| +6% | +$14M | 10.98% | 4 |
|
2014
Q1 | $272M | Sell |
6,301,526
-116,022
| -2% | -$5.01M | 14.04% | 2 |
|
2013
Q4 | $256M | Sell |
6,417,548
-785,037
| -11% | -$31.3M | 13.66% | 3 |
|
2013
Q3 | $270M | Sell |
7,202,585
-566,587
| -7% | -$21.3M | 14.71% | 2 |
|
2013
Q2 | $209M | Buy |
+7,769,172
| New | +$209M | 15.04% | 2 |
|